All Type of News
Boryung Pharm’s ‘Kanarb Tab’ recording highest manufacturing performance last year among Korean new drugs
Among pharmaceutical products approved as new drug developed in Korea, a product which recorded the highest sales was ‘Kanarb Tab,’ a Boryung Pharm’s antihypertensive.
In addition, among the 26 new drugs developed in...
Medicine recorded highest manufacturing performance is ‘Gaswhalmyungsu Soln’
A product with the highest manufacturing performance was ‘Gaswhalmyungsu Soln,’ a Dong Wha Pharm’s digestive medicine.
In addition, 5 OTC medicines including Daewoong Pharmaceutical’s Ursa Tab 1mg were researched to...
Hanmi’s women executive ratio reaches 24%, 10 times higher than average of the top Korean companies
The Hanmi Pharm’s women executive ratio reportedly was close to 24%. The ratio is a figure that is 10 times higher than 2.4%, the average of the top 10 Korean large companies(referencing Chaebul.com on 4 April 2017).
...
Yuhan Corporation acquires ‘Sovaldi’ & ‘Harvoni’ license worth of KRW 120 billion a year
In the official notice on the 5th, Yuhan Corporation announced it signed an exclusive sales agreement of ‘Sovaldi’ and ‘Harvoni,’ hepatitis C treatments, in Korea with U.S. Gilead.
Gilead’s ‘Sovaldi’ and ‘Harvoni’ sa...
Serious conditions with antibiotic tolerance on major pathogens
It was observed it is necessary to nationally prepare measures because antimicrobial resistances on pathogens in Korea are in a serious condition.
In order to calculate standardized data requested by the GLASS(Global...
Pharmaceutical distribution, “We don’t want to get involved with balances accounts for drug price differences”
“Could pharmacies and pharmaceutical companies directly balance accounts for drug price differences each other?”
As the government continues to carry out drug price cuts, pharmaceutical distribution companies have ma...
Subject of bioequivalence test will be extended to powder and granule
Bioequivalence tests, which have only been conducted on tablets, capsules and suppositories, will be extended to powder and granule products from November 2018.
The Ministry of Food and Drug Safety(MFDS) held the ‘Ci...
KPBMA appoints Kyung-Hwa Huh as Vice President of International Business
After the previous appointments for Biopharmaceutical Business and 4th Industry Business, the Korea Pharmaceutical and Bio-Pharma Manufacturers Association(Chairman Hee-Mok Won, KPBMA) appointed Kyung-Hwa Huh, Senior ...
17 pharmaceutical products, such as ‘Zanamivir Cap,’ designated as national essential medicine
‘Zanamivir Cap,’ a H1N1 influenza treatment, was newly designated as the national essential medicine.
The government(Office for Government Policy Coordination, Ministry of Food and Drug Safety, Ministry of Education,...
Hanmi acquired approval of ‘Amosartan Plus,’ 3-substance combination therapy for treatment of hypertension
Hanmi Pharm(CEO Jong-Soo Woo, Sae-Chang Kwon) announced ‘Amosartan Plus,’ a 3-substance combination drug for the treatment of hypertension, acquired commercialization approval from the Ministry of Health and Welfare(M...
